Bacillus velezensis HBXN2020 alleviates Salmonella Typhimurium infection in mice by improving intestinal barrier integrity and reducing inflammation - Wang, Linkang; Wang, Haiyan; Li, Xinxin; Zhu, Mengyuan; Gao, Dongyang; Hu, Dayue; Xiong, Zhixuan; Li, Xiangmin; Qian, Ping (eLife, 2024)
Keywords: Animals; Antibacterial activity; Antibiotics; Antimicrobial activity; Bacillus - physiology; Bacillus velezensis; Bacteria; Biological control; Cecum; Cytokines - metabolism; Disease Models, Animal; Drug resistance; E coli; Female; Genomes; gut health; Ileum; infections; Inflammation; Intestinal microflora; Intestinal Mucosa - metabolism; Intestinal Mucosa - microbiology; Metabolites; Mice; Microbiology and Infectious Disease; Microbiota; Pathogens; Plant diseases; Probiotics; S. Typhimurium infection; Salmonella; Salmonella Infections - microbiology; Salmonella Infections, Animal - microbiology; Salmonella Typhimurium; Salmonella typhimurium - physiology; Spores; Staphylococcus infections; antibacterial activity; S. Typhimurium infection; gut health; infectious disease; infections; microbiology; S. enterica serovar typhi; Bacillus velezensis